GenIP Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0.45	0.52	0.15
Revenue Growth	76.32%	252.52%	-
Cost of Revenue	0.3	0.36	0.13
Gross Profit	0.15	0.16	0.02
Selling, General & Admin	1.32	1.21	0.95
Amortization of Goodwill & Intangibles	0.1	0.1	0.07
Operating Expenses	1.54	1.43	1.01
Operating Income	-1.39	-1.26	-1
Interest Expense	-	-	-0
Interest & Investment Income	0.01	0.01	0
Currency Exchange Gain (Loss)	-	-	-0.07
Pretax Income	-1.39	-1.25	-1.06
Net Income	-1.39	-1.25	-1.06
Net Income to Common	-1.39	-1.25	-1.06
Net Income Growth	-	-	-
Shares Outstanding (Basic)	20	18	18
Shares Outstanding (Diluted)	20	18	18
Shares Change	16.70%	1.43%	-
EPS (Basic)	-0.07	-0.07	-0.06
EPS (Diluted)	-0.07	-0.07	-0.06
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	32.36%	31.66%	12.32%
Operating Margin	-309.99%	-242.25%	-674.62%
Profit Margin	-308.69%	-240.41%	-720.91%
EBITDA	-1.29	-1.16	-0.93
EBITDA Margin	-288.31%	-223.85%	-
D&A For EBITDA	0.1	0.1	0.07
EBIT	-1.39	-1.26	-1
EBIT Margin	-	-242.25%	-